The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, single-arm, efficacy and safety study of poziotinib (NOV120101) in Korean patients with advanced or metastatic lung adenocarcinoma who have acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors.
 
Ji-Youn Han
Honoraria - Novartis
Consulting or Advisory Role - Boehringer Ingelheim
Speakers' Bureau - Pfizer
Research Funding - AstraZeneca; Boehringer Ingelheim; Roche
 
Jin Soo Lee
No Relationships to Disclose
 
Ki Hyeong Lee
No Relationships to Disclose
 
Sang-We Kim
No Relationships to Disclose
 
Young Joo Min
No Relationships to Disclose
 
Eun Kyung Cho
No Relationships to Disclose
 
Young Joo Lee
No Relationships to Disclose
 
Soo-Hyun Lee
No Relationships to Disclose
 
Hyae Young Kim
No Relationships to Disclose
 
Geon Kook Lee
No Relationships to Disclose
 
Byung-Ho Nam
No Relationships to Disclose
 
Jong Hee Han
No Relationships to Disclose
 
Jung Yong Kim
No Relationships to Disclose
 
Jina Jung
Employment - Hanmi